Reach Subsea (REACH)
Oslo Børs · Norway · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 6.100 |
|---|---|
| 52-week range | 4.690 – 7.510 |
| Return, 1 month / 3 months | −7.6% / +23.2% |
| Return, 1 year / 3 years | −8.6% / +57.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 34.9% |
| Worst drawdown (1 year) | -34.6% |
| Average daily value traded | 1.94M NOK |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Reach Subsea is a Norwegian subsea services company based in Haugesund that operates a fleet of vessels and remotely operated vehicles for work beneath the sea surface. It carries out survey, inspection, maintenance and light intervention tasks for customers in the offshore oil and gas and offshore wind industries, along with other marine construction and infrastructure projects. Its crews and equipment support clients who need to examine, repair or maintain underwater installations and seabed assets.
The shares are listed on the Oslo Børs in Norway under the code REACH, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Reach Subsea (REACH) trades on the Oslo Børs in Norway. It last closed at NOK 6.100 on 27 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 157 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.6% and over the last three months it rose 23.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Børs
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.2% | ||
| From 52-week high | -17.7% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 23.2% | ||
| 6-month return | -6.9% | ||
| 12-month return, skipping the last month | -1.1% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.6% | ||
| Liquidity | 49 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 1.94M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 35 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.4% |
|---|---|
| 1 month | −7.6% |
| 3 months | +23.2% |
| 6 months | −6.9% |
| 1 year | −8.6% |
| 3 years | +57.9% |
| 5 years | +154.9% |
Signals
| 50-day / 200-day average | 6.279 / 6.086 |
|---|---|
| Golden / death cross (60 days) | Golden, 12 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.183 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2026 | NOK 0.1700 |
| 30 May 2025 | NOK 0.4200 |
| 3 Jun 2024 | NOK 0.3600 |
| 1 Jun 2023 | NOK 0.1800 |
| 31 May 2022 | NOK 0.1800 |
| 14 Jun 2021 | NOK 0.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Børs; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.